TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3052168

Group type: EXPERIMENTAL
Intervention: Propofol (2.5 mg kg‐1; n = 12)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Etomidate (0.3 mg kg‐1; n = 12)
Number of subjects: 24
Study: 31079510

Group type: EXPERIMENTAL
Intervention: COPing with and CAring for infants with special needs (COPCA)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Typical infant physiotherapy
Number of subjects: 43
Study: 31101954

Group type: EXPERIMENTAL
Intervention: PRT/PCRT followed by breast-conserving surgery (BCS)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: PRT/PCRT followed by mastectomy (ME)
Number of subjects: 107
Study: 28359342

Group type: EXPERIMENTAL
Intervention: RBC transfusion as scheduled
Number of subjects: 0

Group type: COMPARATOR
Intervention: No transfusion
Number of subjects: 0
Study: 25528993

Group type: EXPERIMENTAL
Intervention: Greater optimism
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Lower fatalism
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Absence of family history of cancer
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Being female
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Born in the USA
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Family history of cancer
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Female gender
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Not following the doctor's advice
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Putting off medical problems
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Lower optimism
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Higher fatalism
Number of subjects: 251
Study: 23332501

Group type: EXPERIMENTAL
Intervention: Online course with 3 frontal meetings
Number of subjects: 90

Group type: COMPARATOR
Intervention: Traditional face-to-face course
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Online course
Number of subjects: 90
Study: 22005052

Group type: EXPERIMENTAL
Intervention: Ayahuasca (1.0 mg DMT/kg body weight)
Number of subjects: 10

Group type: COMPARATOR
Intervention: d-amphetamine (20 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 19780472

Group type: EXPERIMENTAL
Intervention: Once weekly iron supplementation (ferrous sulphate at 200 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group received once weekly vitamin C at 100 mg
Number of subjects: 0
Study: 16829031

Group type: EXPERIMENTAL
Intervention: Intranasally administered salmon calcitonin (200 IU/day)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 14521703

Group type: EXPERIMENTAL
Intervention: 30% TCA solution
Number of subjects: 25

Group type: COMPARATOR
Intervention: Cryosurgery
Number of subjects: 25
Study: 11255716

Group type: EXPERIMENTAL
Intervention: Helicoidal CT Scan
Number of subjects: 166

Group type: COMPARATOR
Intervention: Coronary Angiography
Number of subjects: 166
Study: 9382539

Group type: EXPERIMENTAL
Intervention: Intra-arterial infusion chemotherapy with 5-FU + MMC +/- ADR (Group I)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Intra-arterial infusion chemotherapy with CDDP + MMC +/- 5-FU (Group II)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Intra-arterial infusion chemotherapy with radiotherapy
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Intra-arterial infusion chemotherapy without radiotherapy
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Intra-arterial infusion chemotherapy in primary cases
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: All cases of intra-arterial infusion chemotherapy
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Intra-arterial infusion chemotherapy with catheter tip in internal iliac arteries
Number of subjects: 52
Study: 8451057

Group type: EXPERIMENTAL
Intervention: Structured preoperative teaching and written pamphlet on PCA
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual preoperative preparation provided by the physician
Number of subjects: 0
Study: 3530071

Group type: EXPERIMENTAL
Intervention: Danazol 200 mg orally 3 times a day for 30 days
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Danazol 200 mg orally for 6 to 18 months
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Stanazolol 2 mg orally 3 times a day for 30 days
Number of subjects: 56
Study: 30032196

Group type: EXPERIMENTAL
Intervention: Palbociclib plus endocrine therapy
Number of subjects: 1343

Group type: COMPARATOR
Intervention: Endocrine therapy alone (Control)
Number of subjects: 1343
Study: 29316445

Group type: COMPARATOR
Intervention: Platelet-Rich Fibrin (PRF)
Number of subjects: 241

Group type: COMPARATOR
Intervention: Chlorhexidine (0.2%) plus Platelet-Rich Fibrin (PRF-CHX)
Number of subjects: 241

Group type: COMPARATOR
Intervention: Non-Platelet-Rich Fibrin (non-PRF)
Number of subjects: 241

Group type: COMPARATOR
Intervention: Non-Chlorhexidine plus Non-Platelet-Rich Fibrin (non-PRF-CHX)
Number of subjects: 241
Study: 27371264

Group type: EXPERIMENTAL
Intervention: Subcutaneous injection of MMR vaccine before intramuscular injection of DwPT vaccine
Number of subjects: 70

Group type: COMPARATOR
Intervention: Intramuscular injection of DwPT vaccine after MMR
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Both groups (MMR first and DwPT first)
Number of subjects: 70
Study: 24726311

Group type: EXPERIMENTAL
Intervention: Tadalafil 5 mg once daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 23114829

Group type: EXPERIMENTAL
Intervention: Magnetic abutment (test group)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional healing abutment (control group)
Number of subjects: 20
Study: 20660848

Group type: EXPERIMENTAL
Intervention: ASD prescription optimization protocol, patient lists for long-term ASD users, financial compensation for consultations
Number of subjects: 993

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 993

Group type: EXPERIMENTAL
Intervention: ASD prescription optimization protocol
Number of subjects: 993
Study: 18524761

Group type: EXPERIMENTAL
Intervention: Extraction of the primary canine only (EG)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Extraction of the primary canine and cervical‐pull headgear (EHG)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Untreated control group (CG)
Number of subjects: 75
Study: 16298061

Group type: EXPERIMENTAL
Intervention: duloxetine 60 mg QD
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: duloxetine 60 mg BID
Number of subjects: 354

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: duloxetine 60 mg QD or duloxetine 60 mg BID
Number of subjects: 354
Study: 11881159

Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Stress Inoculation Training (SIT)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Combined Treatment (PE/SIT)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Wait List Control (WL)
Number of subjects: 72
Study: 9798179

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Spinal manipulation
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Combination of amitriptyline and spinal manipulation
Number of subjects: 218
Study: 8566980

Group type: EXPERIMENTAL
Intervention: Podophyllotoxin cream 0.5%
Number of subjects: 269

Group type: COMPARATOR
Intervention: Podophyllotoxin solution 0.5% (Condyline)
Number of subjects: 269
Study: 2698562

Group type: EXPERIMENTAL
Intervention: Verapamil 120 mg t.i.d.
Number of subjects: 445

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 445
Study: 1173042

Group type: EXPERIMENTAL
Intervention: Xipamide (4-chloro-5-sulfamoyl-2',6'-salicyloxylidide) administered orally in doses ranging from 0.035 to 0.750 mg/kg body weight
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Xipamide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chlortalidone and furosemid
Number of subjects: 0
Study: 31951510

Group type: EXPERIMENTAL
Intervention: Diode laser (980 nm)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: CO2 laser
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Erbium laser (Er)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: S-Diode (smokers treated with Diode laser)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: S-CO2 (smokers treated with CO2 laser)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: S-Er (smokers treated with Er laser)
Number of subjects: 72
Study: 31242596

Group type: EXPERIMENTAL
Intervention: Mixed spices (5 g daily)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Maltodextrin placebo
Number of subjects: 29
Study: 29187186

Group type: EXPERIMENTAL
Intervention: Clinical Decision Support and Monitoring System (CDSMS) recommendations implemented at physician's discretion
Number of subjects: 439

Group type: COMPARATOR
Intervention: Current DM treatment standards (Control)
Number of subjects: 439
Study: 25921382

Group type: EXPERIMENTAL
Intervention: Capox 50 (capecitabine + oxaliplatin + 50 Gy)
Number of subjects: 598

Group type: COMPARATOR
Intervention: Cap 45 (capecitabine + 45 Gy)
Number of subjects: 598

Group type: EXPERIMENTAL
Intervention: Overall cohort (201 patients)
Number of subjects: 598

Group type: EXPERIMENTAL
Intervention: Clinical complete response
Number of subjects: 598

Group type: EXPERIMENTAL
Intervention: Complete response
Number of subjects: 598
Study: 23670518

Group type: EXPERIMENTAL
Intervention: Stapled hemorrhoidopexy
Number of subjects: 130

Group type: COMPARATOR
Intervention: Milligan-Morgan hemorrhoidectomy
Number of subjects: 130

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 130
Study: 22089042

Group type: EXPERIMENTAL
Intervention: Intradermal lidocaine
Number of subjects: 45

Group type: COMPARATOR
Intervention: No intradermal lidocaine (Control)
Number of subjects: 45
Study: 19220143

Group type: EXPERIMENTAL
Intervention: HSV-2 positive at enrollment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HSV-2 positive during follow-up
Number of subjects: 0

Group type: COMPARATOR
Intervention: HSV-2 negative throughout the study
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Male circumcision
Number of subjects: 0
Study: 17126781

Group type: EXPERIMENTAL
Intervention: 15 mg of isobaric ropivacaine (group R; n = 45)
Number of subjects: 90

Group type: COMPARATOR
Intervention: 7.5 mg of isobaric bupivacaine (group B; n = 45)
Number of subjects: 90
Study: 12580661

Group type: EXPERIMENTAL
Intervention: Reverse Linear Periodization (RLP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Linear Periodization (LP)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Daily Undulating Periodization (DUP)
Number of subjects: 60
Study: 16510631

Group type: EXPERIMENTAL
Intervention: Iron supplementation (30 mg daily)
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (30 mg daily)
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Iron and zinc supplementation (30 mg each daily)
Number of subjects: 602

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 602
Study: 10551574

Group type: EXPERIMENTAL
Intervention: Fiberoptic laryngoscopy (WuScope)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Conventional laryngoscopy (Macintosh blade)
Number of subjects: 87
Study: 8904463

Group type: EXPERIMENTAL
Intervention: Nonpharmacologic techniques
Number of subjects: 8
Study: 1878534

Group type: EXPERIMENTAL
Intervention: Intravenous and/or oral doses of sodium dichloroacetate (DCA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral doses of sodium dichloroacetate (DCA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sodium dichloroacetate (DCA)
Number of subjects: 0
Study: 6193152

Group type: EXPERIMENTAL
Intervention: Intralesional bleomycin, 1 U/ml
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 40
Study: 31769551

Group type: EXPERIMENTAL
Intervention: Flash glucose monitoring
Number of subjects: 12
Study: 28617064

Group type: EXPERIMENTAL
Intervention: Corticosteroid plus local anesthetic
Number of subjects: 41

Group type: COMPARATOR
Intervention: Local anesthetic alone (placebo control)
Number of subjects: 41
Study: 26680007

Group type: EXPERIMENTAL
Intervention: Telephone follow-up programme with eight weekly sessions and a booster session a month later.
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Skill-building strategies addressed through the Caregiver Needs and Concerns Checklist (CNCC).
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Caregiver Needs and Concerns Checklist (CNCC) used to identify and prioritise needs.
Number of subjects: 123
Study: 25118121

Group type: EXPERIMENTAL
Intervention: Preprocedural cardiopulmonary instability and adverse events (IAE)
Number of subjects: 3602

Group type: EXPERIMENTAL
Intervention: Door-to-balloon time (DBT) <99 minutes
Number of subjects: 3602
Study: 21699627

Group type: EXPERIMENTAL
Intervention: Ropinirole prolonged release (2-24 mg/day)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Ropinirole prolonged release
Number of subjects: 198
Study: 19284072

Group type: COMPARATOR
Intervention: Percutaneous coronary intervention (PCI) with bare metal stents in ARTS I
Number of subjects: 0

Group type: COMPARATOR
Intervention: Coronary artery bypass graft (CABG) surgery in ARTS I
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cypher stent implantation in ARTS II
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Comparison of genders in ARTS II
Number of subjects: 0
Study: 17763582

Group type: EXPERIMENTAL
Intervention: Endoscopic carpal tunnel release
Number of subjects: 62

Group type: COMPARATOR
Intervention: Open carpal tunnel release
Number of subjects: 62
Study: 15255442

Group type: EXPERIMENTAL
Intervention: Lyophilized freeze-dried platelet derived preparation
Number of subjects: 28

Group type: COMPARATOR
Intervention: Calcium hydroxide
Number of subjects: 28
Study: 11988802

Group type: EXPERIMENTAL
Intervention: LapSim training (2 hours per week for 5 weeks)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 24
Study: 9613683

Group type: EXPERIMENTAL
Intervention: Filgrastim 5 microg/kg/dy after intensive sequential chemotherapy
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (no filgrastim)
Number of subjects: 46
Study: 7718097

Group type: EXPERIMENTAL
Intervention: Allogeneic leukocyte immunization
Number of subjects: 0
Study: 2810163

Group type: EXPERIMENTAL
Intervention: Caudal analgesia (1 ml 0.2% bupivacaine/kg)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Ilioinguinal block (0.25 ml 0.5% bupivacaine/kg)
Number of subjects: 44
Study: 30890109

Group type: EXPERIMENTAL
Intervention: Brain stem ICH
Number of subjects: 195

Group type: COMPARATOR
Intervention: Cerebellar ICH
Number of subjects: 195
Study: 28494097

Group type: EXPERIMENTAL
Intervention: Azathioprine 1.5-2.5 mg/kg per day with methylprednisolone 0.5 mg/kg per day
Number of subjects: 54

Group type: COMPARATOR
Intervention: Dapsone 1.5 mg/kg per day with methylprednisolone 0.5 mg/kg per day
Number of subjects: 54
Study: 25534356

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (3000 IU)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo (NaCl 0.9%)
Number of subjects: 58
Study: 25148377

Group type: EXPERIMENTAL
Intervention: 400 mg/day fluconazole for 8 days
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 22773109

Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 1620
Study: 19945929

Group type: EXPERIMENTAL
Intervention: Aerobic walking program using heart rate monitor and pedometer for 8 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 40
Study: 17561418

Group type: EXPERIMENTAL
Intervention: Glucosamine hydrochloride and chondroitin sulfate (GH/CS)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study: 16215305

Group type: EXPERIMENTAL
Intervention: Intermittent maximal androgen blockade (IMAB)
Number of subjects: 51
Study: 12130483

Group type: EXPERIMENTAL
Intervention: Filgrastim-mobilized peripheral blood progenitor cells
Number of subjects: 350

Group type: COMPARATOR
Intervention: Bone marrow cells
Number of subjects: 350
Study: 10428127

Group type: EXPERIMENTAL
Intervention: Video-assisted arthroscopic microdiscectomy (Group 2)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Open laminotomy and discectomy (Group 1)
Number of subjects: 60
Study: 7676782

Group type: EXPERIMENTAL
Intervention: Eltanolone 0.6 mg.kg-1 (group E1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Eltanolone 0.8 mg.kg-1 (group E2)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Thiopental 4 mg.kg-1 (group T)
Number of subjects: 60
Study: 2286699

Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 7015131

Group type: EXPERIMENTAL
Intervention: Heroin
Number of subjects: 166

Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 166
Study: 31660904

Group type: COMPARATOR
Intervention: Intense Pulsed Light (IPL) treatment course: 3 times at 3‐week intervals
Number of subjects: 45

Group type: COMPARATOR
Intervention: Intraductal Meibomian Gland Probing (MGP) one time
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Combined MGP followed by IPL treatment course
Number of subjects: 45
Study: 28437225

Group type: EXPERIMENTAL
Intervention: Neck collar with mild jugular vein compression
Number of subjects: 52

Group type: COMPARATOR
Intervention: Non-collar group
Number of subjects: 52
Study: 25854016

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) at shaoyang meridian points
Number of subjects: 110

Group type: COMPARATOR
Intervention: Electroacupuncture (EA) at non-meridian points
Number of subjects: 110
Study: 24073838

Group type: EXPERIMENTAL
Intervention: Oversewing of the staple line (Group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No reinforcement (Group B)
Number of subjects: 60
Study: 21151016

Group type: EXPERIMENTAL
Intervention: Meal Replacements (MR)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Conventional Diet (CD)
Number of subjects: 113

Group type: COMPARATOR
Intervention: All groups (MR+MR, MR+CD, CD)
Number of subjects: 113
Study: 19767384

Group type: EXPERIMENTAL
Intervention: Medtronic MiniMed Paradigm REAL-Time system (PRT group)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Conventional insulin pump therapy (CSII group)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Medtronic MiniMed Paradigm REAL-Time system (PRT group) with protocol compliance
Number of subjects: 132

Group type: COMPARATOR
Intervention: Conventional insulin pump therapy (CSII group) with protocol compliance
Number of subjects: 132
Study: 18075301

Group type: EXPERIMENTAL
Intervention: 1E10 anti-idiotype vaccine (1 mg of 1E10/Alum) administered via five bi-weekly injections followed by 10 doses at 28-day intervals.
Number of subjects: 71
Study: 15506688

Group type: EXPERIMENTAL
Intervention: Calcium aluminate cement (CAC)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Resin composite (RC)
Number of subjects: 46
Study: 11514816

Group type: EXPERIMENTAL
Intervention: Spinal manipulative therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (nonfunctional ultrasound application)
Number of subjects: 30
Study: 9258265

Group type: EXPERIMENTAL
Intervention: Diet plus resistance training
Number of subjects: 21

Group type: COMPARATOR
Intervention: Diet alone
Number of subjects: 21
Study: 7946940

Group type: EXPERIMENTAL
Intervention: Fluconazole 100 mg i.v. single dose
Number of subjects: 10
Study: 2905255

Group type: EXPERIMENTAL
Intervention: roxatidine acetate 75 mg twice daily
Number of subjects: 308

Group type: COMPARATOR
Intervention: ranitidine 150 mg twice daily
Number of subjects: 308
Study: 28870095

Group type: EXPERIMENTAL
Intervention: Chining decoction (CHIN)
Number of subjects: 70

Group type: COMPARATOR
Intervention: recombinant human epidermal growth factor (rhEGF) spray
Number of subjects: 70
Study: 26916363

Group type: EXPERIMENTAL
Intervention: 5.1% weight loss
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 10.8% weight loss
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 16.4% weight loss
Number of subjects: 51

Group type: COMPARATOR
Intervention: Weight maintenance
Number of subjects: 51
Study: 24998106

Group type: EXPERIMENTAL
Intervention: Morphine as first analgesic medication
Number of subjects: 60

Group type: COMPARATOR
Intervention: WHO analgesic ladder (non-opioids, weak opioids, strong opioids)
Number of subjects: 60
Study: 22662739

Group type: EXPERIMENTAL
Intervention: Online education, support, and self-care promotion for caregivers of persons with dementia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Telephone options
Number of subjects: 0
Study: 20538867

Group type: EXPERIMENTAL
Intervention: Spironolactone 25 mg per day
Number of subjects: 420

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 420
Study: 18800887

Group type: EXPERIMENTAL
Intervention: Basswood honey
Number of subjects: 12

Group type: COMPARATOR
Intervention: Honey-comparable glucose-fructose solution
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both solutions (honey and honey-comparable glucose-fructose solution)
Number of subjects: 12
Study: 16311569

Group type: EXPERIMENTAL
Intervention: Teledentistry system (store and forward with photographs sent as email attachments)
Number of subjects: 327

Group type: COMPARATOR
Intervention: Usual letter referral system (control group)
Number of subjects: 327
Study: 11956541

Group type: EXPERIMENTAL
Intervention: Argon beam coagulation (ABC)
Number of subjects: 432

Group type: COMPARATOR
Intervention: Electrocoagulation (EC)
Number of subjects: 432
Study: 9583838

Group type: EXPERIMENTAL
Intervention: High-fat diet (46% fat)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Low-fat diet (24% fat)
Number of subjects: 103
Study: 7624187

Group type: EXPERIMENTAL
Intervention: Experimental results differentiating creative thinking and creativity from psychopathological modes of response
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 87830

Group type: EXPERIMENTAL
Intervention: Adsorbed vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Plain formol toxoid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both vaccines
Number of subjects: 0
Study: 31929124

Group type: EXPERIMENTAL
Intervention: Cenit technique
Number of subjects: 97

Group type: COMPARATOR
Intervention: 2 x 1 technique
Number of subjects: 97